DB
Dr. Vishnu Nayak Badavath
Narsee Monjee Institute of Management Studies University - Hyderabad Campus, Chitkara University, Birla Institute of Technology, Central Drug Research Institute, Hebrew University of Jerusalem
0000-0002-6433-2691
Employment
-
Narsee Monjee Institute of Management Studies University - Hyderabad Campus Assistant Professor2022 - Present
-
Chitkara University Assistant Professor2020 - 2022
-
Hebrew University of Jerusalem Postdoctoral Research Scientist2019 - 2021
-
Chulalongkorn University Faculty of Medicine Postdoctoral Research Scientist2018 - 2019
-
Indian Institute of Technology Postdoctoral Research Scientist2017 - 2018
-
Dr. Reddy's Institute of Life Sciences Research Associate2016 - 2017
-
Brundavan Laboratories Pvt. Ltd. Senior Chemist2016 - 2016
Education
-
Birla Institute of Technology Ph.D2011 - 2016
-
Central Drug Research Institute M.S. (Pham.) Chemistry Project work2010 - 2011
-
National Institute of Pharmaceutical Education and Research M.S. (Pharm.) Chemistry2009 - 2011
-
Osmania University B. Pharmacy2005 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (63)
- Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis Save
- Recent insights into synthesis, biological activities, structure activity relationship and molecular interactions of thiazolidinone hybrids: A systematic review Save
- Anti-Amyloid-β Immunotherapy: A Leading Novel Avenue for Alzheimer's Disease Save
- Crystal growth, optoelectronic and biological properties of acetamidinium compounds: experimental and computational approaches Save
- Ca-EDTA restores the activity of ceftazidime- avibactam or aztreonam against carbapenemase- producing Klebsiella pneumoniae infections Save
- Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection Save
- Determination of potential inhibitors based on isatin derivatives against SARS-CoV-2 main protease (mpro): a molecular docking, molecular dynamics and structure-activity relationship studies Save
- Pharmacophore modeling in drug design Save
- Discovery of 3-chlorobenzyl-linked 1,9-diazaspiro[5.5]undecane derivatives, a lead for dengue virus type 2 infection Save
- Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer’s disease Save